InMode to Participate in Investor Conferences in March
InMode Ltd. (Nasdaq: INMD) announced participation in two investor conferences in March 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD) announced participation in two investor conferences in March 2022. The company will host a virtual fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on March 15, at 10:40 a.m. EST. Additionally, InMode will present in-person at the Barclays Global Healthcare Conference on March 17, at 9:00 a.m. EST, located at the Loews Miami Beach Hotel. These events provide opportunities for one-on-one meetings with investors. For further details, visit InMode's website.
Details
News Market Reaction – INMD
The recorded move for INMD in the trading session of this news was +2.58%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM, Israel, March 2, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in the following investor conferences in March.
Oppenheimer 32nd Annual Healthcare Conference
Format: Virtual fireside chat and one-on-one meetings
When: Fireside chat scheduled for 10:40 a.m. EST on Tuesday, March 15
A live webcast of the presentation can be accessed here.
Barclays Global Healthcare Conference
Format: In-person presentation and one-on-one meetings
Location: Loews Miami Beach Hotel, Miami Beach, Florida
When: Presentation scheduled for 9:00 a.m. EST on Thursday, March 17
A live webcast of the presentation can be accessed here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
+ 1 (0) 917-607-8654
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-investor-conferences-in-march-301493343.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.